APA (7th ed.) Citation

Krishnan, M., Bociek, R. G., Fanale, M., Iyer, S. P., Lechowicz, M. J., Bierman, P. J., . . . Vose, J. M. (2022). Phase 1 trial of carfilzomib in relapsed/refractory peripheral T-cell lymphoma. Annals of hematology, 101(2), 335-340. https://doi.org/10.1007/s00277-021-04692-9

Chicago Style (17th ed.) Citation

Krishnan, Mridula, et al. "Phase 1 Trial of Carfilzomib in Relapsed/refractory Peripheral T-cell Lymphoma." Annals of Hematology 101, no. 2 (2022): 335-340. https://doi.org/10.1007/s00277-021-04692-9.

MLA (9th ed.) Citation

Krishnan, Mridula, et al. "Phase 1 Trial of Carfilzomib in Relapsed/refractory Peripheral T-cell Lymphoma." Annals of Hematology, vol. 101, no. 2, 2022, pp. 335-340, https://doi.org/10.1007/s00277-021-04692-9.